Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device
Neuro-Oncology · 01.12.2025 · 27 (12) · 3161-3173
DOI: 10.1093/neuonc/noaf188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 24.08.2025. Verfasst von Sachi Maeda und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan. Hauptthemen laut MEDLINE: Glioma, Telomerase, Brain Neoplasms, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AMED.
Abstract (Originalsprache)
Background
The 5th edition of the World Health Organization Classification of Tumors of the CNS introduced a subclassification of tumors based on key molecular markers. In adult-type diffuse gliomas, isocitrate dehydrogenase (IDH) and telomerase reverse transcriptase (TERT) promoter mutations play pivotal roles in the molecular classification. This study developed a rapid genotyping system using GeneSoC, a real-time PCR platform with microfluidic thermal cycling capable of completing 50 cycles of PCR within 20 min.
Methods
To establish optimal analytical conditions, frozen tumor tissues from 67 patients and artificial DNA vectors were analyzed using this system. This system demonstrated a detection limit of at least 5% variant allele frequency for the IDH1 R132H and TERT promoter C228T/C250T mutations. Subsequently, intraoperative testing was performed in 120 cases using this system.
Results
The sensitivity and specificity of IDH1 R132H mutation were 0.985 and 0.982, respectively, whereas those of TERT promoter C228T/C250T mutation were 1.000 and 1.000, respectively. These mutations were detected intraoperatively within approximately 25 min after tumor tissue collection. Furthermore, this assay identified tumor boundaries in an IDH-mutated glioma case, where IDH1 R132H mutations could not be detected.
Conclusions
The GeneSoC®︎-based rapid genotyping system may be effective not only for intraoperative diagnosis of diffuse glioma but also for detecting tumor boundaries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
- Department of Neurosurgery, Graduate School of Medicine, Mie University, Tsu, Japan.
- Department of Pathology and Laboratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
- Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Fumiharu Ohka, Kazuya Motomura, Keiko Shinjo
Förderung
- AMED
Zitieren
APA
Maeda, S., Kitano, Y., Ohka, F., Motomura, K., Aoki, K., Deguchi, S., Shiba, Y., Seki, M., Ikeda, Y., Shimizu, H., Iwami, K., Takeuchi, K., Nagata, Y., Yamaguchi, J., Kimura, K., Takido, Y., Yamamoto, R., Nakamura, A., Ito, S., …, & Saito, R. (2025). Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device. Neuro-Oncology, 27(12), 3161-3173. https://doi.org/10.1093/neuonc/noaf188
Vancouver
Maeda S, Kitano Y, Ohka F, Motomura K, Aoki K, Deguchi S, et al. Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device. Neuro-Oncology. 2025;27(12):3161-3173. doi:10.1093/neuonc/noaf188
BibTeX
@article{Maeda2025,
author = {Maeda, Sachi and Kitano, Yotaro and Ohka, Fumiharu and Motomura, Kazuya and Aoki, Kosuke and Deguchi, Shoichi and Shiba, Yoshiki and Seki, Masafumi and Ikeda, Yuma and Shimizu, Hiroki and Iwami, Kenichiro and Takeuchi, Kazuhito and Nagata, Yuichi and Yamaguchi, Junya and Kimura, Keisuke and Takido, Yuhei and Yamamoto, Ryo and Nakamura, Akihiro and Ito, Shohei and Shinjo, Keiko and Kondo, Yutaka and Miyagi, Shohei and Karube, Kennosuke and Saito, Ryuta},
title = {Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {12},
pages = {3161--3173},
doi = {10.1093/neuonc/noaf188}
}
EUVIMED